Cedars-Sinai, for the fourth consecutive year, reports achieving “higher than expected survival rates” in patients receiving blood and marrow transplants.
Cedars-Sinai credits their stellar blood and marrow transplant outcomes “to an outstanding team of dedicated people,” says John Chute, MD, director of the Division of Hematology and Cellular Therapy. In addition to their superb workforce, Cedars-Sinai also credits staying on top of innovative treatments in order to provide patients with the best, most improved care services.
